STX
63
-3
DAL
79
2
ITW
40
3
O
57
2
GT
55
9
GM
79
4
LYB
20
-9
INTU
53
2
APA
52
2
CTSH
63
3
FRT
58
2
FAST
46
4
HIG
56
-7
LNC
65
3
WM
56
3
OMC
53
-2
CHD
34
2
ES
40
-2
AAP
42
3
GD
59
2
STX
63
-3
DAL
79
2
ITW
40
3
O
57
2
GT
55
9
GM
79
4
LYB
20
-9
INTU
53
2
APA
52
2
CTSH
63
3
FRT
58
2
FAST
46
4
HIG
56
-7
LNC
65
3
WM
56
3
OMC
53
-2
CHD
34
2
ES
40
-2
AAP
42
3
GD
59
2
Financhill
Back

Avidity Biosciences, Inc. 10K Form

Buy
72

RNA
Avidity Biosciences, Inc.

Last Price:
$71.53
Seasonality Move:
32.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RNA News And Ratings

See the #1 stock for the next 7 days that we like better than RNA

RNA Financial Statistics

Sales & Book Value

Annual Sales: $10.9M
Cash Flow: $-156.9M
Price / Cash Flow: 0
Annual Sales: $12.85
Price / Book: 5.72

Profitability

EPS (TTM): -4.17020
Net Income (TTM): $-549.8M
Gross Margin: $8.1M
Return on Equity: -37.47%
Return on Assets: -33.66%

Avidity Biosciences, Inc. Earnings Forecast

Key Avidity Biosciences, Inc. Financial Ratios

  • The Gross Profit Margin over the past 8 years for RNA is 74.53%.
  • The Selling, General & Administrative Expenses for RNA have been equal to 791.41% of Gross Profit Margin.
  • The Research & Development expenses have been 2,786.02% of Revenue.
  • The Net Earning history of RNA is -2,957.71% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 3 years.

Avidity Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RNA
CUSIP: 05370A
Website: aviditybiosciences.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 11.57
Quick Ratio: 11.04

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RNA Technical Analysis vs Fundamental Analysis

Buy
72
Avidity Biosciences, Inc. (RNA) is a Buy

Is Avidity Biosciences, Inc. a Buy or a Sell?